
Clinical-stage biopharmaceutical company pioneering innovative treatments for organ fibrosis, scarring and specific autoimmune disorders. $BRBM
Toronto, Vancouver, New York
Joined August 2016
- Tweets14
- Following18
- Followers55
- Likes5
Millions of people live with debilitating conditions and limited treatment options.
BirchBioMed is advancing innovative therapies for organ fibrosis, scarring, skin disorders and autoimmune conditions including Type 1 Diabetes and Alopecia Areata.
🔗: bit.ly/4z4u553
7
162
November is #NationalHealthySkinMonth, highlighting the importance of skin health and the science behind how our bodies heal.
At BirchBioMed, we are advancing research into abnormal scarring and fibrosis through the development of FS2.
8
165
At BirchBioMed, we’re advancing therapies for serious diseases with significant unmet need.
Our pipeline includes FS2 and AI-001, with potential applications across organ fibrosis, autoimmune disorders and severe skin conditions.
Learn more: bit.ly/3WjEfBa
Sensus Healthcare Launches Collaboration with BirchBioMed sensushealthcare.com/press-r…
1
BirchBioMed retweeted
Times Square spotlight shines on @UBC spin-off company @birchbiomed's anti-scarring drug developed at @VCHResearch
BirchBioMed in New York City! Dr. Ghahary and Dr. Hartwell on the sign in Times Square #clinicaltrials #AntiScarring
BirchBioMed retweeted
.@BirchBioMed announces completion of #clinicaltrial for ground-breaking anti-scarring #drug dld.bz/eRwCs
BirchBioMed retweeted
.@BirchBioMed announces completion of #clinicaltrial for ground-breaking anti-scarring #drug dld.bz/eRwCs
BirchBioMed retweeted
.@BirchBioMed announces completion of #clinicaltrial for ground-breaking anti-scarring #drug dld.bz/eRwCs
BirchBioMed announces completion of clinical trial for ground-breaking anti-scarring drug lnkd.in/ebsvUtx
BirchBioMed retweeted
BirchBioMed's ground-breaking therapeutics in the news @BirchBioMed #scarring #autoimmune #biomedical xitter.gq/BirchBioMed/status/769…













